Comparison of Size 1 I-gel & ProSeal Laryngeal Mask

Status Completed

Clinical Trial Summary

Objective of this prospective, randomized and controlled study is to compare the performances of recently-released size 1 I-gel and size 1 PLMA proven to be superior to classical LMA with prospective studies. In this study, primer endpoint was value of airway leak pressure and secondary insertion time, insertion success and conditions, initial airway quality, hemodynamic parameters, fiberoptic view and complications will be assessed.

Clinical Trial Description

Routine monitorization will be performed. Lidocaine 1 mg.kg-1, remifentanil 1 mcg.kg-1 (slow bolus in approximately 1 minute) and 3 mg.kg-1 propofol will be administered in anaesthesia induction.

In Group P, PLMA with fully deflated cuff and applied water-based lubricant, will be inserted using a metal introducer. After insertion, cuff will be inflated with a recommended volume of air and then cuff pressure will be adjusted to 60 cm H2O with manometer.

In Group I, I-gel with its cuff lubricated will be orally inserted along the hard palate until resistance will be felt, as recommended by the manufacturer.

The time between picking up the prepared PLMA (with introducer and deflated cuff) or I-gel and the appearance of the first stable capnographic trace will be recorded as the insertion time. The conditions for insertion will be ere scored according to mouth (1: full, 2: partial, 3: nil), gagging or coughing (1: nil, 2: slight, 3: gross), swallowing (1: nil, 2: slight, 3: gross), head or limb movement (1: nil, 2: slight, 3: gross), laryngospasm (1: nil, 2: slight, 3: complete) and ease of insertion (1: easy, 2: difficult, 3: impossible).

Fresh gas flow will be adjusted to 3 L.min-1, and after closing the expiratory valve the airway pressure at which an audible leak in the mouth occurred will recorded as the 'Pleak'. When Pleak reach 35 cm H2O, expiratory valve will be opened.

Anatomical position of airway device will viewed by inserting fiberoptic bronchoscope through the ventilation tube.

Complications encountered during and at the end of the operation such as desaturation (sPO2 less than 90%), gastric insufflation, aspiration, laryngospasm, bronchospasm and blood stain on the airway device during removal will be recorded. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor)

Related Conditions & MeSH terms

Laryngeal Masks

Clinical Trial Details

NCT number	NCT01704118
Study type	Interventional
Source	Inonu University
Contact
Status	Completed
Phase	N/A
Start date	January 2012
Completion date	October 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03619057` - Voice Tessitura and Size of the Required Laryngeal Mask
Completed	`NCT04206592` - Comparison of the Ambu AuraGain and Intersurgical i-Gel Laryngeal Masks in Elective Laparoscopic Cholecystectomy	N/A
Recruiting	`NCT03725540` - Oropharyngeal Leak Pressure Monitoring Using Baska Versus I-gel Laryngeal Mask Airway
Recruiting	`NCT03528590` - Ventilation Efficacy of Size 3 or Size 4 I-gel in Female Patient Weighing 50 to 60 Kilograms	N/A
Completed	`NCT03118596` - Fibre-optic Guided Tracheal Intubation Through SADs	N/A
Completed	`NCT03139292` - Comparative Evaluation of Ambu AuraGain Laryngeal Mask and Proseal Laryngeal Mask Airway	N/A
Completed	`NCT02938039` - I-Gel vs Ambu Laryngeal Mask Airways in Infants and Children Undergoing Surgical Procedures	N/A
Completed	`NCT01592760` - Air-Q® SP Versus Air-Q® and I-gel	N/A
Not yet recruiting	`NCT04872881` - Comparison of Effectiveness of Different Airway Management Methods During Percutaneous Tracheostomy	Phase 4
Completed	`NCT03852589` - The Effect of Placement of Proseal Laryngeal Mask Airway With C-Mac Videolaryngoscopy	N/A
Completed	`NCT02816463` - RCT:Oropharyngeal Leak Pressure (OLP) - Ambu AuraGain vs LMA Supreme	N/A
Completed	`NCT03140228` - Postoperative Sore Throat in Children: Comparison Between Two Supraglottic Devices, Ambu® AuraOnce™ Laryngeal Mask Airway (LMA) and I-Gel®.	N/A
Completed	`NCT03247803` - Air-Q® SP Versus Williams Intubating Airway for Single-Operator FOI	N/A
Completed	`NCT03257800` - Laryngeal Mask Insertion Conditions And Hemodynamic Effects	N/A
Not yet recruiting	`NCT03502590` - IGEL Laryngeal Mask Airway Device Effectiveness in Irradiated Necks	N/A
Completed	`NCT02618525` - Supraorbital Pressure Versus Jaw Thrust for Assessing the Adequate Depth of Anesthesia for LMA Insertion in Children	N/A
Completed	`NCT04229862` - Effect of Head Elevation on LMA Insertion	N/A
Recruiting	`NCT03931122` - Comparison of Weight-based Versus External Ear-size Based Technique for Selection of Laryngeal Mask Airway in Pediatric Surgical Patients.	N/A
Recruiting	`NCT03006250` - The Effect of Desflurane vs Sevoflurane on Perioperative Respiratory Complications in Laryngeal Mask Airway Anesthesia	Phase 4
Completed	`NCT03028896` - 90° Rotation Technique for LMA FlexibleTM Insertion	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Comparison of Size 1 I-gel and ProSeal Laryngeal Mask

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms